| __timestamp | Axsome Therapeutics, Inc. | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 4279200 | 242549000 |
| Thursday, January 1, 2015 | 6776987 | 245098000 |
| Friday, January 1, 2016 | 21199860 | 147600000 |
| Sunday, January 1, 2017 | 19957616 | 264600000 |
| Monday, January 1, 2018 | 23495055 | 357900000 |
| Tuesday, January 1, 2019 | 53647067 | 1182600000 |
| Wednesday, January 1, 2020 | 70244579 | 357700000 |
| Friday, January 1, 2021 | 58060725 | 540100000 |
| Saturday, January 1, 2022 | 57947447 | 322900000 |
| Sunday, January 1, 2023 | 97944000 | 408000000 |
| Monday, January 1, 2024 | 187077000 |
Cracking the code
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, United Therapeutics Corporation and Axsome Therapeutics, Inc. have showcased contrasting strategies in their R&D investments.
United Therapeutics, a leader in the field, consistently outspent Axsome, with its R&D expenses peaking at approximately $1.18 billion in 2019. This represents a staggering 400% increase from its 2014 spending. Meanwhile, Axsome's R&D expenditure, though significantly lower, has shown a remarkable growth trajectory, surging by over 2,000% from 2014 to 2023.
The year 2023 marked a pivotal moment, with Axsome's R&D spending reaching nearly $98 million, reflecting its aggressive push towards innovation. This financial commitment underscores the dynamic nature of the biotech industry, where strategic investments in R&D can pave the way for groundbreaking advancements.
Analyzing R&D Budgets: Pfizer Inc. vs United Therapeutics Corporation
Research and Development Investment: Takeda Pharmaceutical Company Limited vs Axsome Therapeutics, Inc.
United Therapeutics Corporation or Genmab A/S: Who Invests More in Innovation?
Cost Management Insights: SG&A Expenses for United Therapeutics Corporation and Axsome Therapeutics, Inc.
R&D Insights: How United Therapeutics Corporation and Catalyst Pharmaceuticals, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for United Therapeutics Corporation and Novavax, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Neurocrine Biosciences, Inc. and Axsome Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Axsome Therapeutics, Inc.
Research and Development Expenses Breakdown: Axsome Therapeutics, Inc. vs CRISPR Therapeutics AG
Research and Development Investment: Axsome Therapeutics, Inc. vs Amicus Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Axsome Therapeutics, Inc. and Catalyst Pharmaceuticals, Inc.
R&D Spending Showdown: Axsome Therapeutics, Inc. vs Viridian Therapeutics, Inc.